Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

The Prostate

Showing results (1291-1300 of 5,911) with videos related to

Pageof 592
Sort By:
The Prostate|January 1, 1985
Binding characteristics of inhibin in rat ventral prostateG R Vanage, M A Phadke, A R Sheth
The Prostate|September 22, 2021
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA levelTohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, et al.
The Prostate|July 28, 2022
Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitorsSatı Coşkun Yazgan, Emre Yekedüz, Güngör Utkan, et al.
The Prostate|January 1, 1985
Effects of hyperprolactinemia on the accessory sexual organs of the male ratA Coert, H Nievelstein, H J Kloosterboer, et al.
The Prostate|October 16, 2019
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancerLongjiang Shao, Nermin Kahraman, Ge Yan, et al.
The Prostate|June 30, 2018
A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancerShanshan Zhao, Amy Leonardson, Milan S Geybels, et al.
The Prostate|May 16, 2018
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63Alba Torres, Mohammed Alshalalfa, Elai Davicioni, et al.
The Prostate|August 18, 2018
A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysisShaheen Alanee, Ahmed El-Zawahry, Danuta Dynda, et al.
The Prostate|August 25, 2018
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survivalWanling Xie, Konrad H Stopsack, Sarah J Drouin, et al.
The Prostate|September 27, 2021
Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanismsJeremy Yuen-Chun Teoh, Xiao-Yu Tian, Christine Yim-Ping Wong, et al.
Pageof 592

Showing results (1291-1300 of 5,911) with videos related to

Sort By:
Pageof 592
The Prostate|January 1, 1985
Binding characteristics of inhibin in rat ventral prostateG R Vanage, M A Phadke, A R Sheth
The Prostate|September 22, 2021
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA levelTohru Yoneyama, Hayato Yamamoto, Mihoko Sutoh Yoneyama, et al.
The Prostate|July 28, 2022
Prognostic role of pan-immune-inflammation value in patients with metastatic castration-resistant prostate cancer treated with androgen receptor-signaling inhibitorsSatı Coşkun Yazgan, Emre Yekedüz, Güngör Utkan, et al.
The Prostate|January 1, 1985
Effects of hyperprolactinemia on the accessory sexual organs of the male ratA Coert, H Nievelstein, H J Kloosterboer, et al.
The Prostate|October 16, 2019
Targeting the TMPRSS2/ERG fusion mRNA using liposomal nanovectors enhances docetaxel treatment in prostate cancerLongjiang Shao, Nermin Kahraman, Ge Yan, et al.
The Prostate|June 30, 2018
A five-CpG DNA methylation score to predict metastatic-lethal outcomes in men treated with radical prostatectomy for localized prostate cancerShanshan Zhao, Amy Leonardson, Milan S Geybels, et al.
The Prostate|May 16, 2018
ETS2 is a prostate basal cell marker and is highly expressed in prostate cancers aberrantly expressing p63Alba Torres, Mohammed Alshalalfa, Elai Davicioni, et al.
The Prostate|August 18, 2018
A prospective study to examine the association of the urinary and fecal microbiota with prostate cancer diagnosis after transrectal biopsy of the prostate using 16sRNA gene analysisShaheen Alanee, Ahmed El-Zawahry, Danuta Dynda, et al.
The Prostate|August 25, 2018
Association of genetic variation of the six gene prognostic model for castration-resistant prostate cancer with survivalWanling Xie, Konrad H Stopsack, Sarah J Drouin, et al.
The Prostate|September 27, 2021
Endothelial dysfunction after androgen deprivation therapy and the possible underlying mechanismsJeremy Yuen-Chun Teoh, Xiao-Yu Tian, Christine Yim-Ping Wong, et al.
Pageof 592